Literature for E2072 (M28.010 inhibitor)

Summary Literature

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

    2012
  1. Wozniak,K.M., Wu,Y., Vornov,J.J., Lapidus,R., Rais,R., Rojas,C., Tsukamoto,T. and Slusher,B.S.
    The orally active glutamate carboxypeptidase II inhibitor E2072 exhibits sustained nerve exposure and attenuates peripheral neuropathy
    J Pharmacol Exp Ther343, 746-754. PubMed  Europe PubMed DOI  I